Research Progress in the Treatment of IgG4-related Diseases in Chinese and Western Medicine
DOI:
https://doi.org/10.53469/jcmp.2024.06(09).21Keywords:
IgG4-related diseases, Diagnosis, Chinese and western medicine treatment, Research progressAbstract
IgG4-related diseases (IgG4-RD) is a group of diseases characterized by abnormally elevated levels of IgG4 antibodies and infiltration of IgG4+ plasma cells. Currently, Western medicine mainly uses hormones, immunosuppressants, and biologically targeted therapies for treatment. Traditional Chinese medicine mainly uses dialectic therapy to treat the disease. The syndrome types are mostly Yin deficiency of the liver and kidney, phlegm and blood stasis, Yang deficiency of the spleen and kidney, and damp-heat of the liver and gallbladder. This article provides a review of the research progress in epidemiology, clinical manifestations, diagnosis, and treatment of IgG4-related diseases in Chinese and Western medicine.
References
CHENG Xiaoming, ZHU Huajun, GE Zili. Research progress on Mikulic disease [J]. Journal of Clinical Stomatology, 2022, 38 (07): 438-440.
Wallace ZS, McMahon GA, Hang B, et al. Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index[J]. Semin Arthritis Rheum, 2023, 63:152253.
Lanzillotta Marco, Mancuso Gaia, Della-Torre Emanuel, Advances in the diagnosis and management of IgG4 related disease. [J] .BMJ, 2020, 369: m1067.
Liu Z, Nie Y, Peng Y, et al. The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China[J]. Semin Arthritis Rheum, 2023, 61:152202.
ZHOU Jiaxin, ZHANG Wen. Interpretation of Chinese expert consensus on the diagnosis and treatment of IgG4-related diseases[J].Journal of Clinical Hepatology, 2021, 37(09):2062-2065.
EBBO M, DANIEL L, PAVIC M, et al. IgG4-related systemic disease: Features and treatment response in a French cohort: Results of a multicenter registry[J]. Medicine (Baltimore), 2012, 91(1):49-56. DOI:10.1097/ MD.0b013e3182433d77.
WU Q, CHANG J, CHEN H, et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: A preliminary randomized controlled trial[J]. Int J Rheum Dis, 2017, 20(5): 639-646. DOI:10. 1111/1756-185X. 13088.
GUO Qingmin, ZHAO Xuan, WEN Dawei, et al. THERAPEUTIC EFFECT OF LEFLUNOMIDE IN THE INDUCTION AND MAINTENANCE STAGES OF IGG4-RELATED DISEASES[J].Journal of Qingdao University(Medical Sciences), 2022, 58(06):838-843.
WANG Cong, Zhao Xian, Tian Jianli, et al. lgG4-related retroperitoneal fibrosis: A case report and literature review[J]. Chinese Journal of Geriatrics, 2015, 34(10): 1145-1149.DOI:10.3760/cma.j.issn.0254-9026.2015.10.026.
XUAN Lei, WANG Jing, DONG Zhen-hua. Observation on TCM pattern characteristics and treatment of 20 cases of IgG4-related diseases[J].Beijing Journal of Traditional Chinese Medicine, 2022, 41(06): 682-684. DOI:10.16025/j.1674-1307.2022.06.027.
GAO Ning, Qin Guangning, Zan Shujie, et al. Analysis of the Case Study of Professor Zhang Boli's Application of Zhibai Dihuang Formula in the Treatment of IgG4 Related Diseases[J/OL]. Global Traditional Chinese Medicine, 1-3[2024-08-29].http://kns.cnki.net/kcms/detail/11.5652.R.20240522.0931.002.html.
QIU Tian-tian, LIU Qian-qian, LI Ze-guang. Experience in the Treatment of One Case of IgG4-related Micuriach Disease by TCM Syndrome Differentiation [J]. Rheumatism and Arthritis, 2023, 12(01):28-31.
HE Qing-man, ZHAO Mei, FU Kang-hua, et al. On TCM Treatment of IgG4 Related Diseases from the Theory of "Yang Transforming Qi and Yin Forming Shape" [J]. Rheumatism and Arthritis, 2022, 11(05): 58-61.
MA Gui-qin, ZHANG Ya-nan. Preliminary Study on the Differentiation and Treatment of IgG4 Related Diseases and Related Cases[J].Rheumatism and Arthritis, 2022, 11(09):50-55.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jiahe Tang, Yongxiang Gao
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
